Medicilon IncMedicilon IncMedicilon IncMedicilon Inc
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact

Blog

Home Search results for "Animal Models"

A chemical inflammatory agent that can induce colon cancer model

By medicilon | Featured Stories | Comments are Closed | 7 December, 2020 |

Dextran Sodium Sulfate (DSS) is a synthetic sulfate polysaccharide that can be used as an inflammatory agent to induce colon cancer models in mice. Oral administration of sodium dextran sulfate can directly damage colonic epithelial cells and induce inflammatory reactions by destroying the partition of commensal bacteria in the intestine. Colon cancer is a relativelyRead more

The Role of SiHa Cells in the Establishment of Mouse Cervical Cancer Animal Model

By medicilon | Featured Stories | Comments are Closed | 4 December, 2020 |

Cervical cancer is a disease that seriously threatens women’s lives and health. The establishment of a mouse cervical cancer model can provide an experimental model for the research and development of new drugs and individualized treatments for cervical cancer. Human cervical squamous cell carcinoma SiHa cells are a kind of cells that can be usedRead more

Medicilon Human Disease Animal Model

By medicilon | Featured Stories | Comments are Closed | 1 July, 2020 |

Medicilon provides various effective animal models according to customer needs to test the effectiveness of drugs. Experimental animals include non-human primates, dogs, mice, rats, rabbits, and guinea pigs. At present, we have established a number of effective animal models, and have passed multiple verifications and long-term practical tests. At the same time, our employees’ richRead more

How to choose pre-clinical mouse model?

By medicilon | Featured Stories | Comments are Closed | 16 June, 2020 |

After years of experience accumulation, multi-party verification and long-term practical tests, Medicilon’s Pharmacodynamic Department has established a complete animal model library, which can provide various effective animal models to test the effectiveness of drugs according to customer needs. Laboratory animals include non-human primates, dogs, large mice, rabbits, guinea pigs, minipigs, etc. Tumor modeling techniques includeRead more

Commonly used mouse and nude mouse tumor model names and research

By medicilon | Featured Stories | Comments are Closed | 11 June, 2020 |

1) Research on animal tumor transplantation model level In the initial screening or evaluation of the effectiveness of anti-tumor drugs, the mouse tumor transplantation model was used for in vivo tests. Animal tumor transplantation models often use Kunming or purebred mice to inoculate mouse tumors to observe the inhibitory effect of the test substance onRead more

Introduction of common tumor model experimental animals

By medicilon | Featured Stories | Comments are Closed | 11 June, 2020 |

BALB/c mice Features and uses: ◇ Its incidence is low, but it is sensitive to carcinogens. The incidence of breast tumors is about 10﹪~20﹪. ◇ There are a certain number of ovarian, adrenal and lung tumors, which are extremely sensitive to radiation. You are susceptible to chronic pneumonia.  ◇Most individuals develop immunoglobulin syndrome after 6Read more

Probiotics Are Not Always Good for You

By medicilon | Featured Stories | Comments are Closed | 30 October, 2018 |

Through research on gut inflammation, researchers have found that probiotics are not always ‘good bacteria’, and may not be good for everyone. Studies using a novel human “gut-inflammation-on-a-chip” suggest that probiotic bacteria may not always be a benefit to our health. Woojung Shin, Ph.D. student, and Hyun Jun Kim, Ph.D., assistant professor in the departmentRead more

Novel Parkinson’s Therapies Possible with New Mouse Model

By medicilon | Featured Stories | Comments are Closed | 15 October, 2018 |

Parkinson’s disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women’s Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control.Read more

Protein Regulator of Glioblastoma Migration Identified

By medicilon | Featured Stories | Comments are Closed | 3 October, 2018 |

A specific protein called TEAD1 is an important regulator of tumor migration in glioblastoma, the most common brain tumor in adults, and deactivating this protein may stop tumor cells from migrating away from the main tumor mass, according to research conducted at the Icahn School of Medicine at Mount Sinai.  The data garnered through thisRead more

Excessive Daytime Sleepiness Could Be Linked to Alzheimer’s

By medicilon | Featured Stories | Comments are Closed | 10 September, 2018 |

Alzheimer’s disease is the most common form of dementia.  It affects around 5.7 million people in US – and this number is predicted to rise.  Some estimate that, by 2050, 13.8 million US adults might be affected.  Despite its growing prevalence, treatment options are lacking and there is no cure. The exact causes are notRead more

12345

About Us

  • Medicilon Overview
  • Executive Team
  • Company History
  • CEO Message
  • Honor
  • Customer Reviews
  • New Models of Collaboration
  • Intellectual Property Protection
  • Corporate Culture
  • Careers
  • Download Center
  • Contact

Share

About Us

  • Medicilon Overview
  • Executive Team
  • CEO Message
  • Company History
  • Corporate Culture
  • Honor

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

Customer Center

  • Customer Reviews
  • Download Center
  • Intellectual Property Protection
  • New Models of Collaboration

Contact Us

Shanghai Medicilon Inc.

Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China
Email: Marketing@medicilon.com
Website: www.medicilon.com

Copyright 2017 Shanghai Medicilon inc. | All Rights Reserved Privacy Policy
  • Languages
  • 中国日本대한민국
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact
Medicilon Inc